Arsenic oxide

CAS No. 1327-53-3

Arsenic oxide ( —— )

Catalog No. M19481 CAS No. 1327-53-3

Arsenic trioxide is a chemOthersaputic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Arsenic oxide
  • Note
    Research use only, not for human use.
  • Brief Description
    Arsenic trioxide is a chemOthersaputic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents.
  • Description
    Arsenic trioxide is a chemOthersaputic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents. It is suspected that arsenic trisulfide induces Y cells to undergo apoptosis. Due to the toxic nature of arsenic this drug carries significant health risks. The enzyme thioredoxin reductase has recently been identified as a target for arsenic trioxide.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cancer
  • Indication
    Acute Promyelocytic Leukemia

Chemical Information

  • CAS Number
    1327-53-3
  • Formula Weight
    197.84
  • Molecular Formula
    As2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    [O--].[O--].[O--].[As+3].[As+3]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Babaeivelni K et al. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2014;49(13):1462-73.
molnova catalog
related products
  • Carzenide

    Carzenide is an organic synthesis intermediate, for synthetic drug.

  • NAV-2729

    NAV-2729 inhibits six ArfGEFs (human ARNO, EFA6, BIG1, and BRAG2 and Legionella and Rickettsia RalF), the strongest effects being against BRAG2, Arf1 and Arf6.

  • MNITMT

    MNITMT is a potent immunosuppressive agent without bone marrow toxicity .